Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 3
Journal homepage
300
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, JapanCorrespondence[email protected]
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Eiichi TanakaInstitute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Takahiko KurasawaDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
,
Satoshi KuboThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Kumi ShidaraInstitute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Noriko KimuraDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Hayato NagasawaDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
,
Hideto KamedaDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Koichi AmanoDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
&
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
 show all
Pages 327-338 | Received 01 Aug 2011, Accepted 11 Aug 2011, Published online: 02 Jan 2014

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Tsuneyo Mimori, Junnosuke Ryu, Syuji Takei, Tsutomu Takeuchi, Yoshiya Tanaka, Yoshinari Takasaki, Hisashi Yamanaka, Yuri Yoshizawa, Ichino Chinen, Toru Nakao & Takao Koike. (2019) Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance. Modern Rheumatology 29:5, pages 747-755.
Read now
Yoshiya Tanaka, Tsuneyo Mimori, Hisashi Yamanaka, Ryo Nakajima, Kazuo Morita, Junko Kimura & Tsutomu Takeuchi. (2019) Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan. Modern Rheumatology 29:4, pages 572-580.
Read now
Ayaka Yoshikawa, Shuzo Yoshida, Yuko Kimura, Nao Tokai, Yohei Fujiki, Takuya Kotani, Yoko Matsumura, Tohru Takeuchi & Shigeki Makino. (2018) Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study. Modern Rheumatology 28:2, pages 227-234.
Read now
Juan Chen, Shuhong Chi, Feng Li, Jiali Yang, William C. Cho & Xiaoming Liu. (2017) Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies. Expert Opinion on Biological Therapy 17:3, pages 265-283.
Read now
Yasuharu Nakashima, Hisaaki Miyahara, Masakazu Kondo, Takaaki Fukuda, Hiroshi Harada, Akihisa Haraguchi, Yasushi Inoue, Takashi Ishinishi, Masayuki Maekawa, Akira Maeyama, Munetoshi Nakashima, Eisuke Shono, Eiichi Suematsu, Takashi Shimauchi, Tomomi Tsuru, Hiroshi Tsukamoto, Shigeru Yoshizawa, Seiji Yoshizawa & Yukihide Iwamoto. (2017) Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses. Modern Rheumatology 27:1, pages 15-21.
Read now
Noriko Kimura, Katsuya Suzuki & Tsutomu Takeuchi. (2016) Time lag between the initiation of adalimumab after methotrexate correlates with the efficacy of adalimumab in rheumatoid arthritis patients. Modern Rheumatology 26:5, pages 676-680.
Read now
Vicenç Torrente-Segarra, Ana Urruticoechea Arana, Amalia Sánchez-Andrade Fernández, Juan Víctor Tovar Beltrán, Alejandro Muñoz Jiménez, Anna Martínez-Cristóbal, José Antonio González Ferrández, Manuel Fernández Prada, Noelia Vázquez Fuentes, Hèctor Corominas, Sílvia García-Díaz, Asunción Acosta Pereira, José Miguel Ruiz Martín, José Ramón Lamua Riazuelo, Rosa Expósito Moliner, Desireé Ruiz Vilchez, Raúl Veiga Cabello, Jesús Carlos Fernández, José Raúl Noguera Pons, Noemí Patricia Garrido Puñal, Pedro Giralt Celiméndiz, Raúl Cortés Verdú, Angel Aragón Díez, Carlos Tomás Roura, Concepción Moll Turudi, Delia Taverner Torrent, Felipe Joaquín Rivas Santirso, Juan José Lerma Garrido, Rosa García Portales, Sergi Ordoñez Palau, Silvia Paredes González-Albo, Antonio Gracia Pérez, Arantxa Conesa Mateos, Jaime Calvo Alén, Jenaro Graña Gil, María Pilar Navarro Alonso & María Jesús Martínez Blasco. (2016) study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern Rheumatology 26:3, pages 336-341.
Read now
Eri Sato, Eiichi Tanaka, Ayako Nakajima, Eisuke Inoue, Yoko Shimizu, Rei Yamaguchi, Moeko Ochiai, Kumi Shidara, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2015) Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice. Modern Rheumatology 25:4, pages 528-533.
Read now
Eri Sato, Eiichi Tanaka, Moeko Ochiai, Yoko Shimizu, Akiko Kobayashi, Kumi Shidara, Daisuke Hoshi, Naoki Sugimoto, Eisuke Inoue, Yohei Seto, Ayako Nakajima, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2015) Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012. Modern Rheumatology 25:3, pages 350-357.
Read now
Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Noriaki Yamashita, Noriko Sugiyama, Lorin Craig Wagerle, Bonnie Vlahos & Joseph Wajdula. (2015) Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials. Modern Rheumatology 25:2, pages 173-186.
Read now
Keisuke Izumi, Yuko Kaneko, Hidekata Yasuoka, Noriyuki Seta, Hideto Kameda, Masataka Kuwana & Tsutomu Takeuchi. (2015) Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52. Modern Rheumatology 25:1, pages 31-37.
Read now
Yoshiya Tanaka, Satoshi Kubo, Hisashi Yamanaka, Koichi Amano, Shintaro Hirata, Eiichi Tanaka, Hayato Nagasawa, Hidekata Yasuoka & Tsutomu Takeuchi. (2014) Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia® as Biological Intensive Treatment for RA (ORBIT) study. Modern Rheumatology 24:5, pages 754-762.
Read now
Yohei Seto, Eisuke Inoue, Kumi Shidara, Daisuke Hoshi, Naoki Sugimoto, Eri Sato, Eiichi Tanaka, Ayako Nakajima, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2013) Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. Modern Rheumatology 23:6, pages 1179-1185.
Read now
Toshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, Yuji Hirano, Hisato Ishikawa, Masatoshi Hayashi, Hiroyuki Miyake, Hideki Takagi, Takefumi Kato, Kenya Terabe, Tsuyoshi Wanatabe, Hiroki Tsuchiya, Daihei Kida, Tomone Shioura, Koji Funahashi, Daizo Kato, Hiroyuki Matsubara, Nobunori Takahashi, Yosuke Hattori, Nobuyuki Asai & Naoki Ishiguro. (2013) Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Modern Rheumatology 23:5, pages 977-985.
Read now
Nobunori Takahashi, Toshihisa Kojima, Kenya Terabe, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Takefumi Kato, Naoki Fukaya, Hisato Ishikawa, Masatoshi Hayashi, Seiji Tsuboi, Daizo Kato, Koji Funahashi, Hiroyuki Matsubara, Yosuke Hattori, Masahiro Hanabayashi, Shinya Hirabara, Yutaka Yoshioka & Naoki Ishiguro. (2013) Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients. Modern Rheumatology 23:5, pages 904-912.
Read now

Articles from other publishers (20)

Felicia Ceban & Jiaxi Xu. (2022) The Evolution of TNF-α Blockade for the Treatment of Rheumatoid Arthritis. Journal of Undergraduate Life Sciences 16:1.
Crossref
Zeyad Alzahrani, Ahmed Alhazmi, Hanan Almalki, Noura Aljehani, Mohammed Dumyati & Hadeel Alabdali. (2022) Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia. Cureus.
Crossref
NAGACHIKA SUGISAKI, KURISU TADA, YOSHIYUKI ABE, MICHIHIRO OGASAWARA, RAN MATSUDAIRA, KEN YAMAJI, YOSHINARI TAKASAKI & NAOTO TAMURA. (2020) Clinical Efficacy and Factors Predictive of the Therapeutic Effect of the TNF Inhibitor Golimumab in Patients with Rheumatoid Arthritis. Juntendo Medical Journal 66:1, pages 38-45.
Crossref
Noriko Kimura, Katsuya Suzuki & Tsutomu Takeuchi. (2019) Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab. Inflammation and Regeneration 39:1.
Crossref
Ichiro Yoshii, Tatsumi Chijiwa & Naoya Sawada. (2019) Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients. Clinical Rheumatology 38:12, pages 3351-3360.
Crossref
Naoki Ishiguro, Yoshiya Tanaka, Hisashi Yamanaka, Toshiyuki Yoneda, Takeshi Ohira, Naoki Okubo, Harry K Genant, Désirée van der Heijde & Tsutomu Takeuchi. (2019) Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study. Rheumatology 58:6, pages 997-1005.
Crossref
Ahmadreza Jamshidi, Farhad Gharibdoost, Mahdi Vojdanian, Soosan G. Soroosh, Mohsen Soroush, Arman Ahmadzadeh, Mohammad Ali Nazarinia, Mohammad Mousavi, Hadi Karimzadeh, Mohammad Reza Shakibi, Zahra Rezaieyazdi, Maryam Sahebari, Asghar Hajiabbasi, Ali Asghar Ebrahimi, Najmeh Mahjourian & Amin Mohammadinejad Rashti. (2017) A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis. Arthritis Research & Therapy 19:1.
Crossref
Naoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Shoichi Fukui, Masataka Umeda, Ayako Nishino, Yoshiro Horai, Tomohiro Koga, Shin-ya Kawashiri, Toshiyuki Aramaki, Kunihiro Ichinose, Yasuko Hirai, Mami Tamai, Hideki Nakamura, Kaoru Terada, Tomoki Origuchi, Katsumi Eguchi, Yukitaka Ueki & Atsushi Kawakami. (2017) Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis. PLOS ONE 12:5, pages e0177057.
Crossref
Tsutomu Takeuchi, Ryo Nakajima, Shuichi Komatsu, Kiyotaka Yamazaki, Tomohiro Nakamura, Naoki Agata, Ataru Igarashi, Toshiro Tango & Yoshiya Tanaka. (2017) Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study. Advances in Therapy 34:3, pages 686-702.
Crossref
Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Syuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshinari Takasaki, Tsuneyo Mimori, Katsutoshi Hiramatsu, Shuichi Komatsu & Yoshiya Tanaka. (2015) Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study). Rheumatology and Therapy 3:1, pages 129-141.
Crossref
Toshiaki Kogure, Naoyuki Harada, Kanoko Yamamoto & Takeshi Tatsumi. (2016) Detection of prospective biomarkers of response to Japanese traditional (Kampo) medicines in patients with rheumatoid arthritis using immune response biomarker profiling. Traditional & Kampo Medicine 3:1, pages 3-8.
Crossref
Pedro Santos-Moreno, Guillermo Sánchez, Danny Gómez, Juan Bello-Gualtero & Carlos Castro. (2016) Direct Comparative Effectiveness Among 3 Anti–Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 22:2, pages 57-62.
Crossref
Nobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida, Yuji Hirano, Takefumi Kato, Daizo Kato, Kiwamu Saito, Atsushi Kaneko, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Tsuyoshi Watanabe, Masatoshi Hayashi, Yasuhide Kanayama, Koji Funahashi, Masahiro Hanabayashi, Shinya Hirabara, Shuji Asai, Toki Takemoto, Kenya Terabe, Nobuyuki Asai, Yutaka Yoshioka, Naoki Ishiguro & Toshihisa Kojima. (2015) Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. Rheumatology International 35:10, pages 1707-1716.
Crossref
Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo, Shunsuke Fukuyo, Kentaro Hanami, Norifumi Sawamukai, Kazuhisa Nakano, Shingo Nakayamada, Kunihiro Yamaoka, Fusae Sawamura & Kazuyoshi Saito. (2015) Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study. Annals of the Rheumatic Diseases 74:2, pages 389-395.
Crossref
Koei Oh, Satoshi Ito, Megumi Unno, Daisuke Kobayashi, Chinatsu Azuma, Asami Abe, Hiroshi Otani, Hajime Ishikawa, Kiyoshi Nakazono, Ichiei Narita & Akira Murasawa. (2015) The Rate of Decrease in the Disease Activity of Rheumatoid Arthritis during Treatment with Adalimumab Depends on the Dose of Methotrexate. Internal Medicine 54:9, pages 1035-1041.
Crossref
Uri Kopylov, Talal Al-Taweel, Mohammad Yaghoobi, Benedicte Nauche, Alain Bitton, Peter L. Lakatos, Shomron Ben-Horin, Waqqas Afif & Ernest G. Seidman. (2014) Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: A systematic review and meta-analysis. Journal of Crohn's and Colitis 8:12, pages 1632-1641.
Crossref
Shinya Hirabara, Nobunori Takahashi, Naoki Fukaya, Hiroyuki Miyake, Yuichiro Yabe, Atsushi Kaneko, Takayasu Ito, Takeshi Oguchi, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Fumiaki Sugiura, Masatoshi Hayashi, Koji Funahashi, Masahiro Hanabayashi, Shuji Asai, Naoki Ishiguro & Toshihisa Kojima. (2014) Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies. Clinical Rheumatology 33:9, pages 1247-1254.
Crossref
Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Nobuyuki Miyasaka, Masaya Mukai, Tsukasa Matsubara, Shoji Uchida, Hideto Akama, Hartmut Kupper, Vipin Arora & Yoshiya Tanaka. (2014) Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study. Annals of the Rheumatic Diseases 73:3, pages 536-543.
Crossref
Nobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Takefumi Kato, Naoki Fukaya, Hisato Ishikawa, Masatoshi Hayashi, Seiji Tsuboi, Yasuhide Kanayama, Daizo Kato, Koji Funahashi, Hiroyuki Matsubara, Yosuke Hattori, Masahiro Hanabayashi, Shinya Hirabara, Kenya Terabe, Yutaka Yoshioka & Naoki Ishiguro. (2013) Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity. Clinical Rheumatology 33:1, pages 39-47.
Crossref
XIXI MA & SHENGQIAN XU. (2013) TNF inhibitor therapy for rheumatoid arthritis. Biomedical Reports 1:2, pages 177-184.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.